Pingwei Xu
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Immunology top 5%
- Immune cells in cancer
Papers in
-
- Extracellular vesicles in disease 6
- RNA Interference and Gene Delivery 3
- Immunology 10
- Immune cells in cancer 5
- Immune Cell Function and Interaction 4
- T-cell and B-cell Immunology 2
- Immunotherapy and Immune Responses 2
- Co-authors
- Ke Tang (20 shared papers)Bo Huang (11 shared papers)Jingwei Ma (13 shared papers)Bo Huang (9 shared papers)Huafeng Zhang (4 shared papers)Huafeng Zhang (10 shared papers)Foad Katirai (5 shared papers)Dapeng Li (3 shared papers)
- Journals
- Nature Communications (3 papers)Cancer Immunology Research (3 papers)Nature Materials (2 papers)Nature Cell Biology (2 papers)Cellular and Molecular Immunology (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Pingwei Xu
25 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 118
- Cancer Research 663
- Immunology 524
- Molecular Biology 1.2k
- Oncology 362
- Cell Biology 225
Countries citing papers authored by Pingwei Xu
This map shows the geographic impact of Pingwei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pingwei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pingwei Xu more than expected).
Fields of papers citing papers by Pingwei Xu
This network shows the impact of papers produced by Pingwei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pingwei Xu. The network helps show where Pingwei Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Pingwei Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 402 | |
| 2 | 2012 | 388 | |
| 3 | 2019 | 188 | |
| 4 | 2020 | 169 | |
| 5 | 2017 | 160 | |
| 6 | 2019 | 143 | |
| 7 | 2013 | 135 | |
| 8 | 2020 | 118 | |
| 9 | 2013 | 101 | |
| 10 | 2015 | 69 | |
| 11 | 2018 | 65 | |
| 12 | 2019 | 56 | |
| 13 | 2019 | 53 | |
| 14 | 2020 | 52 | |
| 15 | 2018 | 51 | |
| 16 | 2013 | 40 | |
| 17 | 2017 | 31 | |
| 18 | 2012 | 30 | |
| 19 | 2013 | 29 | |
| 20 | 2016 | 29 |
About Pingwei Xu
Pingwei Xu is a scholar working on Molecular Biology, Immunology, Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 25 papers that have together received 2.4k indexed citations. Recurring topics across this work include Extracellular vesicles in disease (6 papers), Immune cells in cancer (5 papers), Immune Cell Function and Interaction (4 papers), RNA Interference and Gene Delivery (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), T-cell and B-cell Immunology (2 papers), Cancer Cells and Metastasis (2 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Cancer Research (663 citations), Immunology (524 citations), Molecular Biology (1.2k citations), Oncology (362 citations) and Cell Biology (225 citations). Pingwei Xu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Ke Tang, Bo Huang, Jingwei Ma, Bo Huang, Huafeng Zhang, Huafeng Zhang, Foad Katirai, Dapeng Li, Yuying Liu and Duyun Ye. Their work appears in journals such as Nature Communications, Cancer Immunology Research, Nature Materials, Nature Cell Biology and Cellular and Molecular Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.